A citation-based method for searching scientific literature

Daniel R Principe, Suneel D Kamath, Murray Korc, Hidayatullah G Munshi. Pharmacol Ther 2022
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy.
Panagiotis Balermpas, Daniel Martin, Ulrike Wieland, Margret Rave-Fränk, Klaus Strebhardt, Claus Rödel, Emmanouil Fokas, Franz Rödel. Oncoimmunology 2017
55
66

CancerSubtypes: an R/Bioconductor package for molecular cancer subtype identification, validation and visualization.
Taosheng Xu, Thuc Duy Le, Lin Liu, Ning Su, Rujing Wang, Bingyu Sun, Antonio Colaprico, Gianluca Bontempi, Jiuyong Li. Bioinformatics 2017
90
33


Large-scale public data reuse to model immunotherapy response and resistance.
Jingxin Fu, Karen Li, Wubing Zhang, Changxin Wan, Jing Zhang, Peng Jiang, X Shirley Liu. Genome Med 2020
121
33

Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy.
Dongyao Wang, Binqing Fu, Xiaokun Shen, Chuang Guo, Yanyan Liu, Junfei Zhang, Rui Sun, Ying Ye, Jiabin Li, Zhigang Tian,[...]. Signal Transduct Target Ther 2021
3
33

Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, Michael R Green, Andrew J Gentles, Weiguo Feng, Yue Xu, Chuong D Hoang, Maximilian Diehn, Ash A Alizadeh. Nat Methods 2015
33

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, Thomas Powles, Daniel P Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean Hoffman-Censits, Jose Luis Perez-Gracia,[...]. Lancet 2017
33

Landscape of Microsatellite Instability Across 39 Cancer Types.
Russell Bonneville, Melanie A Krook, Esko A Kautto, Jharna Miya, Michele R Wing, Hui-Zi Chen, Julie W Reeser, Lianbo Yu, Sameek Roychowdhury. JCO Precis Oncol 2017
412
33

Predictive biomarkers for response to immune checkpoint inhibition.
Benjamin Shum, James Larkin, Samra Turajlic. Semin Cancer Biol 2022
21
33

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma.
Zaoqu Liu, Siyuan Weng, Hui Xu, Libo Wang, Long Liu, Yuyuan Zhang, ChunGuang Guo, Qin Dang, Zhe Xing, Taoyuan Lu,[...]. Front Oncol 2021
12
33

Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.
Bola S Hanna, Laura Llaó-Cid, Murat Iskar, Philipp M Roessner, Lara C Klett, John K L Wong, Yashna Paul, Nikolaos Ioannou, Selcen Öztürk, Norman Mack,[...]. Immunity 2021
6
33

Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells.
Jingyao Tu, Haoran Xu, Li Ma, Chunya Li, Wan Qin, Xinyi Chen, Ming Yi, Li Sun, Bo Liu, Xianglin Yuan. Theranostics 2022
2
50

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer.
Zaoqu Liu, Long Liu, Siyuan Weng, Chunguang Guo, Qin Dang, Hui Xu, Libo Wang, Taoyuan Lu, Yuyuan Zhang, Zhenqiang Sun,[...]. Nat Commun 2022
26
33

PD-L1 as a biomarker of response to immune-checkpoint inhibitors.
Deborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, Lynette M Sholl, Keith M Kerr, Sacha Gnjatic, Ignacio I Wistuba, David L Rimm, Ming Sound Tsao, Fred R Hirsch. Nat Rev Clin Oncol 2021
141
33

Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma.
Zaoqu Liu, Long Liu, ChunGuang Guo, Sun Yu, Lingfang Meng, Xueliang Zhou, Xinwei Han. Int Immunopharmacol 2021
14
33

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.
Seung Tae Kim, Razvan Cristescu, Adam J Bass, Kyoung-Mee Kim, Justin I Odegaard, Kyung Kim, Xiao Qiao Liu, Xinwei Sher, Hun Jung, Mijin Lee,[...]. Nat Med 2018
584
33

Host tissue determinants of tumour immunity.
Hélène Salmon, Romain Remark, Sacha Gnjatic, Miriam Merad. Nat Rev Cancer 2019
100
33

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, Laurence Zitvogel, Guido Kroemer. Nat Rev Clin Oncol 2020
226
33

Tissue-resident memory T cells in breast cancer control and immunotherapy responses.
Ann Byrne, Peter Savas, Sneha Sant, Ran Li, Balaji Virassamy, Stephen J Luen, Paul A Beavis, Laura K Mackay, Paul J Neeson, Sherene Loi. Nat Rev Clin Oncol 2020
70
33

Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types.
Zaoqu Liu, Chunguang Guo, Jing Li, Hui Xu, Taoyuan Lu, Libo Wang, Long Liu, Xinwei Han. Clin Transl Med 2021
17
33

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Joaquim Bellmunt, Ronald de Wit, David J Vaughn, Yves Fradet, Jae-Lyun Lee, Lawrence Fong, Nicholas J Vogelzang, Miguel A Climent, Daniel P Petrylak, Toni K Choueiri,[...]. N Engl J Med 2017
33

Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies.
Antonio Passaro, Julie Brahmer, Scott Antonia, Tony Mok, Solange Peters. J Clin Oncol 2022
5
33

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
David Liu, Bastian Schilling, Derek Liu, Antje Sucker, Elisabeth Livingstone, Livnat Jerby-Arnon, Lisa Zimmer, Ralf Gutzmer, Imke Satzger, Carmen Loquai,[...]. Nat Med 2019
227
33

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
Daniela Bruni, Helen K Angell, Jérôme Galon. Nat Rev Cancer 2020
289
33

Deciphering cell-cell interactions and communication from gene expression.
Erick Armingol, Adam Officer, Olivier Harismendy, Nathan E Lewis. Nat Rev Genet 2021
136
33

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.
Denis L Jardim, Aaron Goodman, Debora de Melo Gagliato, Razelle Kurzrock. Cancer Cell 2021
86
33

Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation.
Jernej Godec, Yan Tan, Arthur Liberzon, Pablo Tamayo, Sanchita Bhattacharya, Atul J Butte, Jill P Mesirov, W Nicholas Haining. Immunity 2016
150
33

Microsatellite instability in Gastric Cancer: Between lights and shadows.
Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, Silvia Giordano. Cancer Treat Rev 2021
14
33

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer.
Zaoqu Liu, ChunGuang Guo, Qin Dang, Libo Wang, Long Liu, Siyuan Weng, Hui Xu, Taoyuan Lu, Zhenqiang Sun, Xinwei Han. EBioMedicine 2022
25
33

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Sanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe Yuen, Yulei Wang, Edward E Kadel, Hartmut Koeppen, Jillian L Astarita, Rafael Cubas,[...]. Nature 2018
33


Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
A D Santin, P L Hermonat, A Ravaggi, S Bellone, J Roman, S Pecorelli, M Cannon, G P Parham. Int J Radiat Oncol Biol Phys 2000
78
33

Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer.
Yi Zhang, Minhua Yu, Ying Jing, Jiejun Cheng, Caiyan Zhang, Lin Cheng, Haijiao Lu, Mei-Chun Cai, Jie Wu, Wenjing Wang,[...]. Br J Cancer 2021
9
33

Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.
Benjamin Frey, Michael Rückert, Julia Weber, Xaver Mayr, Anja Derer, Michael Lotter, Christoph Bert, Franz Rödel, Rainer Fietkau, Udo S Gaipl. Front Immunol 2017
64
33

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.
Fenne L Komdeur, Thalina M Prins, Stephanie van de Wall, Annechien Plat, G Bea A Wisman, Harry Hollema, Toos Daemen, David N Church, Marco de Bruyn, Hans W Nijman. Oncoimmunology 2017
83
33

Combining radiotherapy with immunotherapy: the past, the present and the future.
Evert J Van Limbergen, Dirk K De Ruysscher, Veronica Olivo Pimentel, Damiënne Marcus, Maaike Berbee, Ann Hoeben, Nicolle Rekers, Jan Theys, Ala Yaromina, Ludwig J Dubois,[...]. Br J Radiol 2017
61
33

Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: The Role of Immune-related Factors.
Innocenza Palaia, Federica Tomao, Anna DI Pinto, Angelina Pernazza, Giusi Santangelo, Nicoletta D'Alessandris, Lucia Manganaro, Antonio Arno, Violante DI Donato, Giorgia Perniola,[...]. In Vivo 2021
3
33

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Jiawen Qian, Chen Wang, Bo Wang, Jiao Yang, Yuedi Wang, Feifei Luo, Junying Xu, Chujun Zhao, Ronghua Liu, Yiwei Chu. J Neuroinflammation 2018
95
33


Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence.
Andreas R de Biasi, Jonathan Villena-Vargas, Prasad S Adusumilli. Clin Cancer Res 2014
156
33

The prognostic landscape of tumor-infiltrating immune cells in cervical cancer.
Jingnan Wang, Zhuoman Li, Aiqin Gao, Qing Wen, Yuping Sun. Biomed Pharmacother 2019
47
33

High versus low dose irradiation for tumor immune reprogramming.
Maria Ochoa de Olza, Jean Bourhis, Melita Irving, George Coukos, Fernanda G Herrera. Curr Opin Biotechnol 2020
8
33

Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
Alina Sturdza, Richard Pötter, Lars Ulrik Fokdal, Christine Haie-Meder, Li Tee Tan, Renaud Mazeron, Primoz Petric, Barbara Šegedin, Ina Maria Jurgenliemk-Schulz, Christel Nomden,[...]. Radiother Oncol 2016
367
33



Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Fernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, David Barras, Isaac Crespo, Massimo Andreatta, Jesus Corria-Osorio, Aodrenn Spill, Fabrizio Benedetti, Raphael Genolet,[...]. Cancer Discov 2022
19
33

The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy.
Minsu Kwon, Hanul Jung, Gi-Hoon Nam, In-San Kim. J Control Release 2021
13
33

Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer.
Emeka K Enwere, Elizabeth N Kornaga, Michelle Dean, Theodora A Koulis, Tien Phan, Maria Kalantarian, Martin Köbel, Prafull Ghatage, Anthony M Magliocco, Susan P Lees-Miller,[...]. Mod Pathol 2017
84
33

Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment.
Ellen N Scott, Angela M Gocher, Creg J Workman, Dario A A Vignali. Front Immunol 2021
19
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.